Skip to Main Content

Paper Details

Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis.
Blood
127
2017
AML, FLT3, FLT3 internal tandem duplication, acute myeloid leukemia, cancer, oncogene, patient, patients, quizartinib, single cells, tumors, tyrosine, tyrosine kinase
Author NameAffiliation
Catherine C Smith
Catherine C SmithHelen Diller Family Comprehensive Cancer Center, University of California san francisco
Kimberly C Lin
Evan Massi
Saurabh AsthanaHelen Diller Family Comprehensive Cancer Center, University of California san francisco
Saurabh AsthanaHelen Diller Family Comprehensive Cancer Center, University of California san francisco
Adam B OlshenHelen Diller Family Comprehensive Cancer Center, University of California san francisco
Adam B OlshenUniversity of California san francisco
Mark J LevisSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Mark J LevisSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Jerald P RadichFred Hutchinson Cancer Research Center
Neil P Shah
Neil P ShahHelen Diller Family Comprehensive Cancer Center, University of California san francisco
  • 1 - 13

Datasets

Release 1.2